Complex of peptide fractions Taxorest N60 obtained from the bronchial mucosa of young animals. The isolated peptides have a selective effect on the cells of the bronchial mucosa, normalize metabolism in them, and increase their functional activity.
Clinical studies have established the effectiveness of the drug "Taxorest" for restoring the functional activity of the bronchi in cases of disturbances of various origins, including exposure to extreme environmental factors, after acute and chronic diseases of the respiratory system of infectious and non-infectious origin, including chronic bronchitis and bronchitis of smokers, for bronchial asthma, as well as during aging to maintain the function of the respiratory system.
Contains peptides of the bronchial mucosa
Recommended:
for chronic bronchitis
for smoker's bronchitis
for bronchial asthma
for chronic obstructive pulmonary disease
for chronic heart failure
after suffering diseases of the bronchi and lungs of various origins
Composition of the product
Peptide complex A-19 (bronchial peptides), MCC carrier; capsule shell (hydroxypropyl methylcellulose, purified water, carrageenan, potassium acetate), anti-caking agent calcium salt of stearic acid.
Instructions for use:
1-2 capsules 1-2 times a day with meals. Duration of treatment is 1-3 months. It is advisable to repeat the course after 1-3 months.
Release form: 60 capsules, 0.2 g each